Drug Shortage Report for DAXAS

Last updated on 2019-01-10
Report ID 68907
Drug Identification Number 02359456
Brand name DAXAS
Common or Proper name roflumilast
Company Name ASTRAZENECA CANADA INC
Active Ingredient(s) Roflumilast
Strength(s) 500MCG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 tablets
ATC code R03DX
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-11-27
Estimated end date 2019-01-10
Actual end date 2019-01-08
Shortage status Resolved
Updated date 2019-01-10
Company comments
Health Canada comments
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.